Sign In
Buy ATHA
$6.61
+0 (+0%)
At Close: Apr 14, 2026
Athira Pharma - ATH-1017: Panacea Or Pandora's Box?
11:19am, Wednesday, 30'th Jun 2021
Athira shares plunged over 39% on June 18 after founder/CEO Leen Kawas was placed on temporary leave due to an ongoing review into her doctoral research at Washington State University. The review is e
NEW YORK, June 30, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a Lead Plaintiff motion in a securities class act
NEW YORK, June 29, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of class action lawsuits on behalf of purchasers of the securities of Athira Pharma
Athira Shareholder Alert
08:46pm, Tuesday, 29'th Jun 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
Keller Rohrback Files Suit Against Athira Pharma for Misrepresentations in IPO Registration Statement
06:35pm, Tuesday, 29'th Jun 2021
SEATTLE--(BUSINESS WIRE)--Keller Rohrback filed a lawsuit against Athira Pharma, certain of its officers and directors, and the underwriters of the IPO of Athira common stock.
Los Angeles, California--(Newsfile Corp. - June 29, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma,
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)
12:30pm, Tuesday, 29'th Jun 2021
LOS ANGELES--(BUSINESS WIRE)---- $ATHA #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 24, 2021 deadline to file a lead plaintiff motion in the class act
Biotech firm Athira Pharma hit by class action lawsuits following image manipulation claims
12:03pm, Tuesday, 29'th Jun 2021
The lawsuits have begun.
NEW YORK, June 29, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Athira Pharma, Inc. ("Athira�
SAN FRANCISCO, June 28, 2021 /PRNewswire/ -- Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class action has been fil
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States Distric
LOS ANGELES--(BUSINESS WIRE)---- $ATHA #ATHA--SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc.
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of class action lawsuits on behalf of purchasers of the securities of Athira Pharma, Inc. (NASDA
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
03:00pm, Monday, 28'th Jun 2021
New York, New York--(Newsfile Corp. - June 28, 2021) - Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA). Such investors a
Notice of Lead Plaintiff Deadline for Shareholders in the Athira Pharma, Inc. Class Action Lawsuit – ATHA
02:53pm, Monday, 28'th Jun 2021
SAN DIEGO--(BUSINESS WIRE)-- #ATHAHstock--The suit alleges defendants issued false statements concerning Athira business and prospects, resulting in its stock trading at inflated prices.
